Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,193.34 17.37 0.55%
FTSE 100 6,700.20 25.46 0.38%
DAX 9,596.16 51.97 0.54%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,561.05 51.41 0.23%

The National Comprehensive Cancer Network, The US Oncology Network and McKesson Specialty Health collaborate to offer new Value



  The National Comprehensive Cancer Network, The US Oncology Network and
  McKesson Specialty Health collaborate to offer new Value Pathways for cancer
  care

Collaboration aims to create new, evidence-based clinical quality standards in
the oncology market and address cost trends

Business Wire

FORT WASHINGTON, Pa. -- November 29, 2012

The National Comprehensive Cancer Network^® (NCCN^®), The US Oncology Network,
and McKesson Specialty Health are collaborating to develop enhanced oncology
pathways delivered through innovative technology, which will strengthen
standards in evidence-based, high-quality cancer care and enable new forms of
transparent provider and payer relationships. Value Pathways powered by NCCN
are the next step in a collaboration to deliver a first-of-its-kind clinical
quality and regimen support system, building upon a solution initially
developed by Proventys, Inc. as CDS Oncology. This workflow-integrated
software will allow physicians to assess treatment options consistent with
evidence-based standards at the point of care. Value Pathways powered by NCCN,
delivered through the clinical quality and regimen support system, is an
important step forward in ensuring patients receive the highest quality
treatment, while offering options to address the costs of cancer care.

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) — the most
comprehensive and most frequently updated clinical practice guidelines
available in any area of medicine — will serve as the foundational evidence
source within the clinical quality and regimen support system and be
supplemented by the collaboratively-developed Value Pathways. Anchored in
clinical quality and evidence-based medicine, Value Pathways powered by NCCN
will build upon The US Oncology Network’s Level I Pathways and help patients
receive the highest-quality care with the best opportunity for positive
outcomes, while also recognizing the importance of value in determining
appropriate treatment options. These pathways will provide payers and
employers with quality-based pathways, developed by trusted oncologist-led
sources through a transparent process, suitable to drive value-based
reimbursement programs.

Leading physicians of The US Oncology Network, supported by McKesson Specialty
Health, will work with Guideline Panel oncologists from NCCN Member
Institutions to develop the Pathways, which will initially cover 19 tumor
types and be expanded to match the breadth of NCCN Guidelines^®. Value
Pathways powered by NCCN will reflect the collaborative effort of nearly 2,000
physicians and oncology researchers affiliated with NCCN Guidelines Panels and
The US Oncology Network. Ongoing development of Value Pathways will be
100-percent concordant with NCCN Guidelines and leverage the pathways
development process pioneered by The US Oncology Network’s Level I Pathways
and Pathways Task Force.

“NCCN Guidelines are recognized as the gold standard across the industry. Our
collaboration builds upon that by pairing them with new Value Pathways powered
by NCCN to create a single set of content that we believe will enhance
national best practices for optimal patient care and value-based outcomes in a
completely transparent process,” said Roy Beveridge, M.D., chief medical
officer for McKesson Specialty Health and The US Oncology Network. “The
physician-led approach to developing meaningful clinical content – including
rigorous peer review and updates based on the best science available – is a
natural match between our organizations and our complementary expertise will
enable us as an industry to measure, track and drive quality cancer care using
the best, most up-to-date medicine.”

Developed by physicians for physicians, Value Pathways powered by NCCN will be
available in the spring of 2013 as part of the clinical quality and regimen
support system. This first-of-its-kind software will allow physicians to
review treatment options and their relevant clinical attributes against both
Value Pathways and NCCN Guidelines at the point of care, and integrated within
their workflow — creating a new technology and clinical quality standard in
oncology. By placing emphasis on outcomes, the system will allow oncologists
to access the most recent evidence available in the delivery of high-quality
cancer care.

“Through the clinical quality and regimen support system and Value Pathways
powered by NCCN, our goal is to enable oncologists to access the most recent
evidence available in the delivery of high-quality cancer care,” said Dr.
Robert Carlson, incoming chief executive officer of NCCN. “This collaboration
provides physicians with up-to-date, peer-reviewed, evidence-based practice
guidelines for cancer detection, prevention and risk reduction, biomarkers
recommendations, diagnosis, treatment, and supportive care for a multitude of
disease sites.”

The clinical quality and regimen support system will allow physicians to
access evidence-based content at the point of care and will be compatible with
multiple leading Electronic Health Record (EHR) systems, increasing efficiency
within the practice, as well as quality and cost effectiveness.

“We are excited to work with McKesson Specialty Health and The US Oncology
Network to offer Value Pathways and the NCCN Guidelines within the clinical
quality and regimen support system,” said Patricia J. Goldsmith, executive
vice president and chief operating officer for NCCN. “Our guidelines and Level
I Pathways have helped clinicians and payers address variations in treatment
and improve oncology cost trends through emphasis on the quality of care. We
aim to use our combined expertise to continue this mission and enhance care by
offering one standard set of content, through a new accessible format.”

About McKesson Specialty Health

McKesson Specialty Health, a division of McKesson Corporation, empowers the
community patient care delivery system by helping community practices advance
the science, technology and quality of care. Through innovative clinical,
research, business and operational solutions, facilitated by integrated
technology systems, we focus on improving the financial health of our
customers so they may provide the best care to their patients. For more
information, visit www.mckessonspecialtyhealth.com.

About the National Comprehensive Cancer Network^® (NCCN^®)

The National Comprehensive Cancer Network^® (NCCN^®), a not-for-profit
alliance of 21 of the world’s leading cancer centers, is dedicated to
improving the quality and effectiveness of care provided to patients with
cancer. Through the leadership and expertise of clinical professionals at NCCN
Member Institutions, NCCN develops resources that present valuable information
to the numerous stakeholders in the health care delivery system. As the
arbiter of high-quality cancer care, NCCN promotes the importance of
continuous quality improvement and recognizes the significance of creating
clinical practice guidelines appropriate for use by patients, clinicians, and
other health care decision-makers. The primary goal of all NCCN initiatives is
to improve the quality, effectiveness, and efficiency of oncology practice so
patients can live better lives. In furtherance of such purposes, NCCN has
developed proprietary content for the provision of cancer care, including
without limitation, the NCCN Clinical Practice Guidelines in Oncology (NCCN
Guidelines^®), the NCCN Drugs & Biologics Compendium (NCCN Compendium^®), the
NCCN Chemotherapy Order Templates (NCCN Templates^®), as well as other
valuable resources.

The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center,
Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts
General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC;
Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the
University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research
Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel
Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie
Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial
Sloan-Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL;
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital
and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute,
Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington
University School of Medicine, St. Louis, MO; St. Jude Children’s Research
Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford
Cancer Institute, Stanford, CA; University of Alabama at Birmingham
Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family
Comprehensive Cancer Center, San Francisco, CA; University of Michigan
Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The
Nebraska Medical Center, Omaha, NE; The University of Texas MD Anderson Cancer
Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.

Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.com.

About The US Oncology Network

The US Oncology Network is one of the nation’s largest networks of
community-based oncology physicians dedicated to advancing cancer care in
America. Like-minded physicians are united through The Network around a common
vision of expanding patient access to high-quality, integrated cancer care in
communities throughout the nation. Leveraging healthcare information
technology, shared best practices, refined evidence-based medicine guidelines,
and quality measurements, physicians affiliated with The US Oncology Network
are committed to advancing the quality, safety, and science of cancer care to
improve patient outcomes. The US Oncology Network is supported by McKesson
Specialty Health, a division of McKesson Corporation focused on empowering a
vibrant and sustainable community patient care delivery system to advance the
science, technology and quality of care. For more information, visit
www.usoncology.com.

Contact:

Media Contacts:
NCCN
Katie Kiley Brown, 215-690-0238
brown@nccn.org
or
McKesson Specialty Health
Claire Crye, 281-863-6783
claire.crye@mckesson.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement